ProCure Treatment Centers

ProCure Treatment Centers specializes in advanced cancer treatment using proton therapy, offering precise targeting of tumors while minimizing damage to adjacent healthy tissues. Their innovative approach caters to a variety of cancer types, enhancing patient outcomes. ProCure Treatment Centers focuses on delivering proton therapy for cancer treatment. The company was acquired by Central DuPage Health, Inc in September 2013.

Founded by Gabriel Jabbour and Rehan Tufail, ProCure is headquartered in New York, US. Gabriel Jabbour has a history of entrepreneurial ventures, contributing to ProCure's foundation. ProCure Proton Therapy Center specializes in delivering state-of-the-art cancer treatment through proton therapy, a highly advanced form of radiation therapy. Proton therapy functions by directing proton particles precisely into tumors, minimizing damage to surrounding healthy tissues and thereby reducing side effects commonly associated with traditional X-ray radiation treatments.

This service caters to various cancer types, including prostate, breast, brain, head and neck cancers, as well as pediatric tumors. ProCure's facilities are equipped with the latest technology, including Pencil Beam Scanning, which enhances treatment accuracy. The center primarily serves patients throughout New Jersey and collaborates with leading health institutions nationwide, extending its impact to a broader geographical market, including affiliations with Hackensack Meridian Health, NYU, and Northwell Health. ProCure Proton Therapy Center generates revenue primarily through direct patient services, focusing on proton therapy treatments.

The company structures its client transactions on a direct-to-consumer basis, where patients engage in consultations that lead to personalized treatment plans. Treatment costs are typically process-based, aligning with the complexity and duration of the therapy required. The center offers comprehensive packages that may include initial consultations, treatment sessions, and follow-up care. ProCure's approach emphasizes not only the efficacy of proton therapy but also the overall wellbeing of its patients, ensuring that the service remains competitive while fostering long-term relationships with patients seeking advanced cancer treatment solutions.

ProCure Treatment Centers plans to utilize its recent funding of USD 40. 00 mn from Maverick Ventures to expand its services and reach new markets. The company aims to enhance its product offerings and is actively developing advanced treatment options expected to launch in the coming years. ProCure also seeks to expand its geographical footprint beyond New Jersey, targeting strategic partnerships with additional health institutions, leveraging their existing collaborations to explore new regional opportunities.